Refractory cold agglutinin disease successfully treated with daratumumab. A case report and review of literature
<h3>Background</h3><p dir="ltr">Cold agglutinin disease (CAD) is immune-mediated hemolytic anemia. The disease is caused by cold reactive autoantibodies that induce hemolysis through the activation of the complement pathway. Most patients with CAD are elderly, and half ma...
Saved in:
| Main Author: | |
|---|---|
| Other Authors: | , , |
| Published: |
2023
|
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|